Cargando...
Liraglutide preconditioning attenuates myocardial ischemia/ reperfusion injury via homer1 activation
Myocardial infarction (MI) is one of most common cardiovascular diseases, and ischemia/reperfusion (I/R) injury is one of the risk factors for severe myocardial injury and dysfunction, even leading to high mortality of myocardial infarction. Liraglutide, a novel glucagon-like peptide 1 (GLP-1) analo...
Guardado en:
| Publicado en: | Aging (Albany NY) |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Impact Journals
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7993747/ https://ncbi.nlm.nih.gov/pubmed/33535171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.202429 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|